Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Moiseeva

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
JACC. Cardiovascular Interventions|March 23, 2024
Carlino-Like Technique for Retrograde Recanalization of Chronic Thromboembolic Pulmonary Artery OcclusionNarek Marukyan, Dmitrii Zubarev, Artem Gorbatykh, et al.
Oncogene|January 9, 2004
Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescenceFrédérick A Mallette, Stéphane Goumard, Marie-France Gaumont-Leclerc, et al.
BMC Evolutionary Biology|October 2, 2007
Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancerEric Villiard, Henner Brinkmann, Olga Moiseeva, et al.
Molecular Cytogenetics|February 20, 2016
Ring chromosome 18 in combination with 18q12.1 (DTNA) interstitial microdeletion in a patient with multiple congenital defectsAnna Zlotina, Tatiana Nikulina, Natalia Yany, et al.
Pulmonary Circulation|January 23, 2025
PET/CT Imaging of the Right Heart Perfusion and Glucose Metabolism Depending on a Risk Status in Patients With Idiopathic Pulmonary Arterial HypertensionNatalia Goncharova, Daria Ryzhkova, Kirill Lapshin, et al.
Cell Cycle (Georgetown, Tex.)|June 2, 2015
Mutant lamin A links prophase to a p53 independent senescence programOlga Moiseeva, Frédéric Lessard, Mariana Acevedo-Aquino, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescenceFrédérick A Mallette, Olga Moiseeva, Viviane Calabrese, et al.
Frontiers in Immunology|April 18, 2022
Case Report: Multiple Causes of Cardiac Death After the First Infusion of Atezolizumab: Histopathological and Immunohistochemical FindingsEkaterina Kushnareva, Maria Stepanova, Elizaveta Artemeva, et al.
Cancer Research|May 22, 2016
A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced SenescenceMariana Acevedo, Mathieu Vernier, Lian Mignacca, et al.
Annals of Thoracic Medicine|February 10, 2025
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertensionGoncharova Natalia, Kirill Lapshin, Aelita Berezina, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
JACC. Cardiovascular Interventions|March 23, 2024
Carlino-Like Technique for Retrograde Recanalization of Chronic Thromboembolic Pulmonary Artery OcclusionNarek Marukyan, Dmitrii Zubarev, Artem Gorbatykh, et al.
Oncogene|January 9, 2004
Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescenceFrédérick A Mallette, Stéphane Goumard, Marie-France Gaumont-Leclerc, et al.
BMC Evolutionary Biology|October 2, 2007
Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancerEric Villiard, Henner Brinkmann, Olga Moiseeva, et al.
Molecular Cytogenetics|February 20, 2016
Ring chromosome 18 in combination with 18q12.1 (DTNA) interstitial microdeletion in a patient with multiple congenital defectsAnna Zlotina, Tatiana Nikulina, Natalia Yany, et al.
Pulmonary Circulation|January 23, 2025
PET/CT Imaging of the Right Heart Perfusion and Glucose Metabolism Depending on a Risk Status in Patients With Idiopathic Pulmonary Arterial HypertensionNatalia Goncharova, Daria Ryzhkova, Kirill Lapshin, et al.
Cell Cycle (Georgetown, Tex.)|June 2, 2015
Mutant lamin A links prophase to a p53 independent senescence programOlga Moiseeva, Frédéric Lessard, Mariana Acevedo-Aquino, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescenceFrédérick A Mallette, Olga Moiseeva, Viviane Calabrese, et al.
Frontiers in Immunology|April 18, 2022
Case Report: Multiple Causes of Cardiac Death After the First Infusion of Atezolizumab: Histopathological and Immunohistochemical FindingsEkaterina Kushnareva, Maria Stepanova, Elizaveta Artemeva, et al.
Cancer Research|May 22, 2016
A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced SenescenceMariana Acevedo, Mathieu Vernier, Lian Mignacca, et al.
Annals of Thoracic Medicine|February 10, 2025
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertensionGoncharova Natalia, Kirill Lapshin, Aelita Berezina, et al.
Pageof 5